EU health agency studies possible link between J&J Covid vaccine and blood clots

(RFI) – After looking into Vaxzevria, the AstraZeneca/Oxford vaccine, the European Medicines Agency (EMA) is now investigating the Johnson & Johnson vaccine for a possible link to the occurrence of blood clots. This comes just shortly before its expected rollout on the continent.

EMA’s “Pharmovigilance Risk Assessment Committee (Prac) had “launched a study” intended “to assess information on thromboembolic incidents” involving people who have received the Johnson & Johnson vaccine, according to the statement.

Three of these cases were found in US after local authorities had approved the vaccine.

A fourth one -in an unnamed country- resulted in the death of a person during a test phase.

Read more of this report

(Visited 30 times, 1 visits today)
About Cholo Brooks 14494 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.

Be the first to comment

Leave a Reply

Your email address will not be published.